# Enveric Biosciences, Inc.: filings

ENVB · Nasdaq · CIK 890821 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/envb.md) · [Financials](/companies/envb/financials.md) · [Filings](/companies/envb/filings.md) · [Insiders](/companies/envb/insiders.md)

## Reports and events: 396 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 225, 4 174, 10-Q 53, 3 45, UPLOAD 44, CORRESP 41, SC 13D/A 24, EFFECT 20, 8-K/A 18, 10-K 17, 424B5 16, SC 13G/A 15, DEF 14A 14, S-1/A 13, SC 13G 13, 424B3 12, 425 12, SCHEDULE 13G 12, PRE 14A 11, 10-Q/A 9, S-3 9, SC 13D 9, D 8, S-1 8, SCHEDULE 13G/A 8, 10-K/A 6, S-4/A 6, S-8 6, DEFA14A 5, 424B4 4, ARS 4, S-3/A 4, 4/A 3, D/A 2, NT 10-K 2, NT 10-Q 2, S-4 2, 10-KT 1, 25-NSE 1, 3/A 1, 8-A12B 1, 8-A12G 1, 8-A12G/A 1, CERTNAS 1, DEF 14C 1, FWP 1, POS AM 1, PRE 14C 1, PRER14A 1, S-3MEF 1, S-4MEF 1, SC 14F1 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-14 | 16:21 ET | [10-Q](/filings/0001493152-26-038418.md) | Quarterly report, period 2026-06-30 | 0001493152-26-038418 |
| 2026-08-14 | 16:15 ET | [8-K](/filings/0001493152-26-038385.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-038385 |
| 2026-06-09 | 17:16 ET | [8-K](/filings/0001493152-26-027976.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-027976 |
| 2026-06-09 | 17:53 ET | [8-K](/filings/0001493152-26-027781.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-027781 |
| 2026-05-29 | 16:13 ET | [8-K](/filings/0001493152-26-026364.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-026364 |
| 2026-05-15 | 08:05 ET | [10-Q](/filings/0001493152-26-023353.md) | Quarterly report, period 2026-03-31 | 0001493152-26-023353 |
| 2026-05-15 | 08:00 ET | [8-K](/filings/0001493152-26-023345.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-023345 |
| 2026-04-30 | 16:02 ET | [8-K](/filings/0001493152-26-020410.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-020410 |
| 2026-04-20 | 18:15 ET | [8-K](/filings/0001493152-26-017960.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-017960 |
| 2026-04-14 | 16:05 ET | [DEF 14A](/filings/0001493152-26-016543.md) | Proxy statement, period 2026-04-14 | 0001493152-26-016543 |
| 2026-03-27 | 17:27 ET | [10-K](/filings/0001493152-26-013294.md) | Annual report, period 2025-12-31 | 0001493152-26-013294 |
| 2026-03-27 | 17:25 ET | [8-K](/filings/0001493152-26-013290.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-013290 |
| 2026-02-10 | 21:28 ET | [S-1](/filings/0001493152-26-005852.md) | Registration statement | 0001493152-26-005852 |
| 2026-02-06 | 16:45 ET | [8-K](/filings/0001493152-26-005606.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-005606 |
| 2026-01-28 | 17:00 ET | [8-K](/filings/0001493152-26-004055.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-004055 |
| 2026-01-09 | 17:23 ET | [8-K](/filings/0001493152-26-001151.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-001151 |
| 2025-12-12 | 17:10 ET | [8-K](/filings/0001493152-25-027541.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-027541 |
| 2025-12-11 | 12:41 ET | [8-K](/filings/0001493152-25-027196.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-25-027196 |
| 2025-11-14 | 16:31 ET | [10-Q](/filings/0001493152-25-023540.md) | Quarterly report, period 2025-09-30 | 0001493152-25-023540 |
| 2025-11-14 | 16:05 ET | [8-K](/filings/0001493152-25-023444.md) | 8.01 Other events | 0001493152-25-023444 |
| 2025-11-14 | 16:05 ET | [8-K](/filings/0001493152-25-023441.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-023441 |
| 2025-10-27 | 16:30 ET | [DEF 14A](/filings/0001493152-25-019750.md) | Proxy statement, period 2025-10-27 | 0001493152-25-019750 |
| 2025-10-23 | 16:30 ET | [8-K](/filings/0001493152-25-019095.md) | 3.01 Delisting notice; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-019095 |
| 2025-09-18 | 16:30 ET | [8-K](/filings/0001493152-25-014073.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-014073 |
| 2025-09-02 | 08:30 ET | [8-K](/filings/0001641172-25-026143.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-026143 |
| 2025-08-29 | 17:16 ET | [8-K](/filings/0001641172-25-026054.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-026054 |
| 2025-08-29 | 17:10 ET | [8-K](/filings/0001641172-25-026040.md) | 3.01 Delisting notice | 0001641172-25-026040 |
| 2025-08-14 | 16:08 ET | [10-Q](/filings/0001641172-25-024021.md) | Quarterly report, period 2025-06-30 | 0001641172-25-024021 |
| 2025-08-14 | 08:00 ET | [8-K](/filings/0001641172-25-023724.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-023724 |
| 2025-06-03 | 16:30 ET | [8-K](/filings/0001641172-25-013466.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001641172-25-013466 |
| 2025-05-14 | 16:59 ET | [10-Q](/filings/0001641172-25-010345.md) | Quarterly report, period 2025-03-31 | 0001641172-25-010345 |
| 2025-05-14 | 16:15 ET | [8-K](/filings/0001641172-25-010275.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-010275 |
| 2025-04-15 | 09:15 ET | [DEF 14A](/filings/0001641172-25-004717.md) | Proxy statement, period 2025-04-15 | 0001641172-25-004717 |
| 2025-04-14 | 14:27 ET | [8-K](/filings/0001641172-25-004320.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001641172-25-004320 |
| 2025-03-31 | 08:00 ET | [8-K](/filings/0001641172-25-001486.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-001486 |
| 2025-03-28 | 17:19 ET | [10-K](/filings/0001641172-25-001296.md) | Annual report, period 2024-12-31 | 0001641172-25-001296 |
| 2025-03-06 | 09:30 ET | [8-K](/filings/0001493152-25-009336.md) | 8.01 Other events | 0001493152-25-009336 |
| 2025-02-26 | 08:30 ET | [8-K](/filings/0001493152-25-008281.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-008281 |
| 2025-02-03 | 17:30 ET | [8-K](/filings/0001493152-25-004715.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-004715 |
| 2025-01-30 | 17:10 ET | [S-1/A](/filings/0001493152-25-004292.md) | Registration statement, amended | 0001493152-25-004292 |
| 2025-01-30 | 08:01 ET | [S-1/A](/filings/0001493152-25-004213.md) | Registration statement, amended | 0001493152-25-004213 |
| 2025-01-27 | 06:10 ET | [8-K/A](/filings/0001493152-25-003676.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-25-003676 |
| 2025-01-21 | 17:10 ET | [8-K](/filings/0001493152-25-003091.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-25-003091 |
| 2025-01-14 | 17:09 ET | [S-1](/filings/0001493152-25-002214.md) | Registration statement | 0001493152-25-002214 |
| 2025-01-03 | 16:15 ET | [8-K](/filings/0001493152-25-000247.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-000247 |
| 2024-12-18 | 08:30 ET | [DEF 14A](/filings/0001493152-24-050536.md) | Proxy statement, period 2024-12-18 | 0001493152-24-050536 |
| 2024-11-22 | 16:45 ET | [8-K](/filings/0001493152-24-047420.md) | 3.01 Delisting notice | 0001493152-24-047420 |
| 2024-11-14 | 16:10 ET | [10-Q](/filings/0001493152-24-045859.md) | Quarterly report, period 2024-09-30 | 0001493152-24-045859 |
| 2024-11-14 | 16:05 ET | [8-K](/filings/0001493152-24-045840.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-045840 |
| 2024-11-12 | 09:00 ET | [8-K](/filings/0001493152-24-044572.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-044572 |

Page 1 of 8. [Older](/companies/envb/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:59 ET. No prices; not investment advice.